Pinning down cell signaling, cancer and Alzheimer's disease

Trends in Biochemical Sciences

Volumn 29, Issue 4, 2004, Pages 200-209

  Lu, Kun Ping ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOMERASE; PROLINE; SERINE; THREONINE;

AGE; ALZHEIMER DISEASE; CANCER; CELL FUNCTION; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME STRUCTURE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; CDC2-CDC28 KINASES; CELL CYCLE; CYCLIN-DEPENDENT KINASE 2; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NEOPLASMS; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PHOSPHOSERINE; PHOSPHOTHREONINE; PROLINE; PROLINE-DIRECTED PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 1842763560     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2004.02.002     Document Type: Review

References (75)

1. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 411:2001;355-365.
2. Lu K.P., et al. Pinning down the proline-directed phosphorylation signaling. Trends Cell Biol. 12:2002;164-172.
3. Lu K.P. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell. 4:2003;175-180.
4. Geschwind D.H. Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg. Neuron. 40:2003;457-460.
5. Lee M.S., Tsai L.H. Cdk5: one of the links between senile plaques and neurofibrillary tangles? J. Alzheimers Dis. 5:2003;127-137.
6. Lu K.P., et al. Proline-directed phosphorylation and isomerization in mitotic regulation and in Alzheimer's disease. Bioessays. 25:2003;174-181.
7. Lu K.P., et al. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature. 380:1996;544-547.
8. Yaffe M.B., et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science. 278:1997;1957-1960.
9. Ranganathan R., et al. Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent. Cell. 89:1997;875-886.
10. Shen M., et al. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 12:1998;706-720.
11. Lu P.J., et al. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature. 399:1999;784-788.
12. Zhou X.Z., et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell. 6:2000;873-883.
13. Winkler K.E., et al. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science. 287:2000;1644-1647.
14. Wulf G.M., et al. Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J. 20:2001;3459-3472.
15. Ryo A., et al. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 3:2001;793-801.
16. Fujimori F., et al. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem. Biophys. Res. Commun. 265:1999;658-663.
17. Liou Y.C., et al. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. U. S. A. 99:2002;1335-1340.
18. Stukenberg P.T., Kirschner M.W. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell. 7:2001;1071-1083.
19. Hsu T., et al. Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis. Nat. Cell Biol. 3:2001;538-543.
20. Wulf G.M., et al. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 277:2002;47976-47979.
21. Zheng H., et al. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature. 419:2002;849-853.
22. Zacchi P., et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature. 419:2002;853-857.
23. Messenger M.M., et al. Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions. J. Biol. Chem. 277:2002;23054-23064.
24. Ryo A., et al. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell. 12:2003;1413-1426.
25. Lu P.J., et al. Critical role of WW domain phosphorylation in regulating its phosphoserine-binding activity and the Pin1 function. J. Biol. Chem. 277:2002;2381-2384.
26. Ryo A., et al. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J. Cell Sci. 116:2003;773-783.
27. Liou Y.-C., et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature. 424:2003;556-561.
28. Atchison F.W., et al. Spermatogonial depletion in adult Pin1-deficient mice: Pin1 regulates the timing of mammalian primordial germ cell proliferation. Biol. Reprod. 69:2003;1989-1997.
29. Atchison F.W., et al. Pin1 regulates the timing of mammalian primordial germ cell proliferation. Development. 130:2003;3579-3586.
30. Ayala G., et al. Pin1 is a novel prognostic marker in prostate cancer. Cancer Res. 63:2003;6244-6251.
31. Bao, L. et al. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. (in press).
32. Fischer G., Aumuller T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev. Physiol. Biochem. Pharmacol. 148:2003;105-150.
33. Weiwad M., et al. Evidence that the substrate backbone conformation is critical to phosphorylation by p42 MAP kinase. FEBS Lett. 478:2000;39-42.
34. Brown N.R., et al. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell Biol. 1:1999;438-443.
35. Uchida T., et al. Identification and characterization of a 14 kDa human protein as a novel parvulin-like peptidyl prolyl cis/trans isomerase. FEBS Lett. 446:1999;278-282.
36. Lu P.J., et al. A function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science. 283:1999;1325-1328.
37. Jacobs D.M., et al. Peptide binding induces large scale changes in inter-domain mobility in human Pin1. J. Biol. Chem. 278:2003;26174-26182.
38. Verdecia M.A., et al. Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat. Struct. Biol. 7:2000;639-643.
39. Wintjens R., et al. 1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides. J. Biol. Chem. 276:2001;25150-25156.
40. Rippmann J.F., et al. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ. 11:2000;409-416.
41. Holzer M., et al. Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol. (Berl.). 104:2002;471-481.
42. Ramakrishnan P., et al. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. Neurobiol. Dis. 14:2003;251-264.
43. Ryo A., et al. Pin1 is an E2F target gene essential for the Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 22:2002;5281-5295.
44. You H., et al. IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J. Cell. Biochem. 84:2002;211-216.
45. Basu A., et al. Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation. Neoplasia. 4:2002;218-227.
46. Papa F.R., et al. Bypassing a kinase activity with an ATP-competitive drug. Science. 302:2003;1533-1537.
47. He J., et al. Cell cycle-dependent phosphorylation of disabled-2 by cdc2. Oncogene. 22:2003;4524-4530.
48. Ley, R. et al. Extracellular signal-regulated kinases 1/2 are serum-stimulated 'BimEL-kinases' that bind to the BH3-only protein BimEL causing its phosphorylation and turnover. J. Biol. Chem. (in press).
49. Li H., et al. Structure of human Ki67 FHA domain and its binding to a phosphoprotein fragment from hNIFK reveal unique recognition sites and new views to the structural basis of FHA domain functions. J. Mol. Biol. 335:2004;371-381.
50. Xu Y.X., et al. Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev. 17:2003;2765-2776.
51. Palancade B., et al. Dephosphorylation of RNA polymerase II by CTD-phosphatase FCP1 is inhibited by phospho-CTD associating proteins. J. Mol. Biol. 335:2004;415-424.
52. Ubersax J.A., et al. Targets of the cyclin-dependent kinase Cdk1. Nature. 425:2003;859-864.
53. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:2002;E131-E136.
54. Bienz M. The subcellular destinations of APC proteins. Nat. Rev. Mol. Cell Biol. 3:2002;328-338.
55. Moon R.T., et al. The promise and perils of Wnt signaling through beta-catenin. Science. 296:2002;1644-1646.
56. Lin S.Y., et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4262-4266.
57. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 109(Suppl):2002;S81-S96.
58. Karin M., et al. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer. 2:2002;301-310.
59. Ben-Neriah Y. Pinning NF-κB to the nucleus. Mol. Cell. 12:2003;1344-1345.
60. Shaw P.E. Peptidyl-prolyl isomerases: a new twist to transcription. EMBO Rep. 3:2002;521-526.
61. Wu X., et al. The Ess1 prolyl isomerase is linked to chromatin remodeling complexes and the general transcription machinery. EMBO J. 19:2000;3727-3738.
62. Wu X., et al. Genetic interactions between the ESS1 prolyl-isomerase and the RSP5 ubiquitin ligase reveal opposing effects on RNA polymerase II function. Curr. Genet. 40:2001;234-242.
63. Kops O., et al. Pin1 enhances the dephosphorylation of the C-terminal domain of the RNA polymerase II by Fcp1. FEBS Lett. 513:2002;305-311.
64. Arevalo-Rodriguez M., et al. Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase. EMBO J. 19:2000;3739-3749.
65. Hani J., et al. Mutations in a peptidylprolyl-cis/trans-isomerase gene lead to a defect in 3′-end formation of a pre-mRNA in Saccharomyces cerevisiae. J. Biol. Chem. 274:1999;108-116.
66. Wahl G.M., Carr A.M. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat. Cell Biol. 3:2001;E277-E286.
67. Ryan, K. M. and Vousden, K. H. (2002) Cancer: pinning a change on p53. Nature 419, 795, 797.
68. Nevins J.R. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10:2001;699-703.
69. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:2002;353-356.
70. Alonso A., et al. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. U. S. A. 98:2001;6923-6928.
71. Hennig L., et al. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry. 37:1998;5953-5960.
72. Zhang Y., et al. Substrate-based design of reversible Pin1 inhibitors. Biochemistry. 41:2002;11868-11877.
73. Uchida T., et al. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem. Biol. 10:2003;15-24.
74. Hampel H., et al. Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231. Ann. Neurol. 49:2001;545-546.
75. Bayer E., et al. Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding. J. Biol. Chem. 278:2003;26183-26193.